NanoViricides (NYSE-A:NNVC) said on Wednesday it has completed manufacturing of its NV-387 oral drug product, clearing a key ...
SHELTON, CT / ACCESS Newswire / March 11, 2026 / NanoViricides, Inc. (AMEX:NNVC) (the "Company"), a clinical stage ...
The prevention and control of communicable disease relies on a number of well-established interventions. Vaccination, vector ...
Toronto Public Health reported two cases of the mpox variant clade Ib. These are the first cases of this variant in Toronto and across the province.